Indanyl carbenicillin in chronic recurrent urinary tract infections.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D002228:Carbenicillin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D003556:Cystitis / Q000188:drug therapy; D003967:Diarrhea / Q000139:chemically induced; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D007192:Indenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D012008:Recurrence; D012706:Serratia marcescens; D014552:Urinary Tract Infections / Q000188:drug therapy*
D007192:Indenes; D002228:Carbenicillin